Commenting on baricitinib versus tocilizumab in mechanically ventilated patients with COVID-19

JAMES CHENG-CHUNG WEI2026-10-162026-10-162024-12-01Pure ID: 15422659Pure UUID: 40e08fb2-373e-4513-8721-05fc9f02bc8d10.1186/s13054-024-05116-6https://www.scopus.com/pages/publications/85208602438https://scholars.csmu.edu.tw/handle/123456789/24031enCommenting on baricitinib versus tocilizumab in mechanically ventilated patients with COVID-19a nationwide cohort studyjournal article